PD-L1 positivity (≥25% of tumor membrane expression) was frequent in TET (65%), more common in thymomas compared to thymic carcinomas, and associated with longer OS compared to PD-L1 negative tumors [median OS (mOS) 87 months versus 29 months]. The gene discussed is CD274; the disease is thymoma.